NEW YORK, Aug. 1, 2024 /PRNewswire/ — The global digital diabetes management market size is estimated to grow by USD 19.12 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 21.99% during the forecast period. Rising global burden of diabetes is driving market growth, with a trend towards integration of ai in wearable medical devices. However, stringent regulatory framework in digital diabetes management poses a challenge. Key market players include Abbott Laboratories, B.Braun SE, Becton Dickinson and Co., DarioHealth Corp., Dassault Systemes SE, decide Clinical Software GmbH, Dexcom Inc., F. Hoffmann La Roche Ltd., Glooko Inc., GlucoMe Ltd., Informed Data Systems Inc. And One Drop., Insulet Corp., LifeScan IP Holdings LLC, Medtronic Plc, Orpyx Medical Technologies Inc., PHC Holdings Corp., Sharecare Inc., SOCIALDIABETES SL, Tandem Diabetes Care Inc., and WaveForm Technologies Inc..
Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report
Digital Diabetes Management Market Scope
Report Coverage
Details
Base year
2023
Historic period
2018 – 2022
Forecast period
2024-2028
Growth momentum & CAGR
Accelerate at a CAGR of 21.99%
Market growth 2024-2028
USD 19.12 billion
Market structure
Fragmented
YoY growth 2022-2023 (%)
21.14
Regional analysis
North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution
North America at 46%
Key countries
US, Germany, France, UK, and China
Key companies profiled
Abbott Laboratories, B.Braun SE, Becton Dickinson and Co., DarioHealth Corp., Dassault Systemes SE, decide Clinical Software GmbH, Dexcom Inc., F. Hoffmann La Roche Ltd., Glooko Inc., GlucoMe Ltd., Informed Data Systems Inc. And One Drop., Insulet Corp., LifeScan IP Holdings LLC, Medtronic Plc, Orpyx Medical Technologies Inc., PHC Holdings Corp., Sharecare Inc., SOCIALDIABETES SL, Tandem Diabetes Care Inc., and WaveForm Technologies Inc.
Market Driver
The digital diabetes management market is experiencing significant growth due to increased innovation and technological advancements. Manufacturers are designing more compact, light, and ergonomic wearable medical devices using technologies such as system-on-chip (SoC) and chip-scale package (CSP). Devices like the MiniMed 670G system and KTrack Glucose offer advanced features, such as automated insulin delivery and real-time glucose monitoring on a smartwatch. The FreeStyle Libre system by Abbott, a 14-day continuous glucose monitoring system, is another example of technological innovation. The integration of AI into mobile-based diabetic management and the availability of advanced products have revolutionized diabetic monitors. Smart wearable diabetic management systems with wireless technology are becoming increasingly popular. These advancements are expected to drive the growth of the global digital diabetes management market during the forecast period.
Digital diabetes management is a growing market with innovative trends transforming diabetes care solutions. Apps, cloud-based enterprise solutions, and AI technology lead the way. AI and machine learning use algorithms to analyze data from handheld devices, wearable devices, and smart insulin meters for continuous glucose monitoring. Insulin delivery devices like smart insulin pumps, closed-loop pumps, and wearable insulin patches offer automated insulin delivery and dosing algorithms. Data management software and big data analytics help healthcare providers monitor diabetes patients remotely. Obesity management is also a focus with fitness trackers, wearable medical devices, and smartwatches. Type 1 and Type 2 diabetes patients benefit from exercise guidance, insulin monitoring, and insulin injection guidance. Digital technologies are revolutionizing diabetes care, reducing patient visits, and improving lifestyle patterns.
Discover 360° analysis of this market. For complete information, schedule your consultation – Book Here!
Market Challenges
The digital diabetes management market is witnessing significant growth due to the increasing prevalence of diabetes and the modernization of medical devices. However, stringent medical device regulations in both Europe and the US pose challenges for vendors offering advanced digital diabetes management devices. The US FDA classifies diabetes care management devices as Class II, and failure to comply with these regulations can lead to product recalls, negatively impacting a company’s brand reputation. For instance, F. Hoffmann-La Roche experienced a recall of its ACCU-CHEK Flex Link Plus infusion sets due to kinked or bent cannulas, leading to under-delivery of insulin and potential elevation of blood glucose levels. Vendors must undergo rigorous postmarket approvals to ensure compliance with these regulations and maintain patient safety. The regulatory focus on robust surveillance systems, enhanced postmarket regulations, and improved monitoring of devices in Europe and the US can potentially hamper market growth during the forecast period.The digital diabetes management market is growing rapidly as more diabetes patients turn to remote monitoring and digital technologies for managing their condition. Big data analytics and AI technology are key drivers, enabling real-time insulin monitoring, injection guidance, and diabetes prediction. Remote patient monitoring through wearable medical devices like fitness trackers, smartwatches, and activity monitors, as well as handheld devices and smartphone apps, are popular solutions. Hospitals, diagnostic centers, and home settings are major segments. Challenges include ensuring accuracy and reliability, integrating with insulin delivery devices like insulin pens and patches, and addressing the needs of Type 1 and Type 2 diabetes patients. Healthcare providers must adapt to these digital solutions to improve patient outcomes and reduce costs. Digital technologies like automated insulin delivery and insulin dosing algorithms are revolutionizing diabetes care, while lifestyle patterns and pancreas function analysis are essential for effective management.
For more insights on driver and challenges – Request a sample report!
Segment Overview
This digital diabetes management market report extensively covers market segmentation by
End-user 1.1 Hospitals1.2 Home settings1.3 Diagnostic centersType 2.1 Wearable devices2.2 Hand-held devicesGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)
1.1 Hospitals- The hospital segment in digital diabetes management refers to the utilization of digital tools and technologies for diabetes management within healthcare facilities. This segment encompasses mobile applications, online platforms, electronic health records (EHRs), medical devices, and telehealth services. Hospitals employ remote patient monitoring through glucose monitoring devices, enabling continuous blood sugar level tracking and prompt action. Diabetes education and self-management resources are provided via interactive tools, mobile apps, and online courses. EHRs facilitate access to accurate patient data, enhancing care coordination and reducing medical errors. Telehealth services offer remote consultations, saving patients time and money, while medical device integration enables real-time data collection and analysis. Data analytics and decision support systems help healthcare professionals identify trends and insights for personalized treatment plans. By implementing digital solutions, hospitals enhance patient care, expand access to healthcare services, and empower patients to actively manage their diabetes, fueling the growth of the global digital diabetes management market.
For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report
Research Analysis
Digital diabetes management refers to the use of technology to help diabetes patients effectively manage their condition. This includes a range of solutions such as apps, cloud-based enterprise solutions, and handheld devices. Artificial intelligence (AI) and machine learning algorithms are increasingly being used to analyze big data and provide personalized insulin monitoring, diabetes prediction, exercise guidance, and more. Obesity, a common comorbidity in diabetes, can also be addressed through digital solutions that promote healthy lifestyle choices. Remote patient monitoring allows healthcare providers to keep track of patients’ glucose levels and other vital signs in real-time, whether in hospitals, diagnostic centers, or home settings. Solutions like smart insulin pens, insulin pumps, patches, and smartwatches are making diabetes management more convenient and efficient for patients. AI technology is also being explored for closed-loop systems that can automatically adjust insulin doses based on real-time glucose readings. The geriatric population, a growing segment of diabetes patients, can particularly benefit from these digital solutions due to their ease of use and ability to improve health outcomes.
Market Research Overview
Digital diabetes management refers to the use of technology and digital health solutions to help diabetes patients effectively manage their condition. This includes a range of offerings such as diabetes care apps, cloud-based enterprise solutions, and handheld devices. Artificial intelligence (AI) and machine learning algorithms are increasingly being used to analyze patient data, including glucose levels, lifestyle patterns, and insulin dosing, to provide personalized insulin monitoring, injection guidance, and diabetes prediction. Wearable devices like smartwatches, fitness trackers, and continuous glucose monitoring systems are also popular in digital diabetes management. Obesity, a common comorbidity in diabetes, can also be addressed through these solutions. Digital diabetes management caters to both Type 1 and Type 2 diabetes patients in various settings, including hospitals, home settings, and diagnostic centers. Big data analytics and AI technology enable healthcare providers to remotely monitor patients and offer timely interventions. Insulin delivery devices, such as smart insulin pumps, closed-loop pumps, and smart insulin patches, are also part of the digital diabetes management landscape. Digital technologies are transforming diabetes care, making it more accessible, personalized, and effective.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
End-userHospitalsHome SettingsDiagnostic CentersTypeWearable DevicesHand-held DevicesGeographyNorth AmericaEuropeAsiaRest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/digital-diabetes-management-market-size-is-set-to-grow-by-usd-19-12-billion-from-2024-2028–rising-global-burden-of-diabetes-boost-the-market-technavio-302210982.html
SOURCE Technavio
Technology4 days ago
Technology2 days ago
Technology5 days ago
Coin Market5 days ago
Technology4 days ago
Coin Market4 days ago